Abstract

Brachytherapy is a modality of radiotherapy which treats tumors using ionizing radiation with sources located close to the tumor. The sources can be produced from several radionuclides in various formats, such as Iodine‑125 seeds and Iridium‑192 wires. In order to produce a new Iodine‑125 seed in IPEN/CNEN and ensure its quality, it is essential to describe the dosimetry of the seed, so when applied in a treatment the lowest possible dose to neighboring healthy tissues can be reached. The report by the AAPM’s Task Group 43 U1 is a document that indicates the dosimetry procedures in brachytherapy based on physical and geometrical parameters. In this study, dose-rate constant and air-kerma strength parameters were simulated using the Monte Carlo method radiation transport code MCNP4C. The air-kerma strength is obtained from an ideal modeled seed, since its actual value should be measured for seeds individually in a specialized lab with a Wide-Angle Free-Air Chamber (WAFAC). Dose-rate constant and air-kerma strength are parameters that depends on intrinsic characteristics of the source, i.e. geometry, radionuclide, encapsulation, and together they define the dose-rate to the reference point, defined as the dose-rate to a point 1 cm away from the geometric center of the source, in its transverse plane. This study presents the values found for these parameters with associated statistical uncertainty, and is part of a larger project that aims the full dosimetry of this new seed model, including experimental measures.

Highlights

  • Cancer is the name of a set of diseases that affect the cells of the body resulting from an anomalous uncontrolled development with genetic mutations that were not suppressed

  • In order to reduce the price for certain types of cancer treatments with brachytherapy and allow this treatment to reach more patients, IPEN/CNEN is developing a new Iodine-125 seed

  • The objective of this work is to carry out part of the dosimetric characterization of this Iodine-125 seed relying on Monte Carlo simulations. [2]

Read more

Summary

Introduction

Cancer is the name of a set of diseases that affect the cells of the body resulting from an anomalous uncontrolled development with genetic mutations that were not suppressed. The treatment can be done in different combinations of surgery, radiotherapy, hormonal treatment and chemotherapy according to the specificities of each case as analyzed by the group of physicians responsible for the case. The fundamental difference is the location of the radioactive source relative to the body of the patient. The sources used in brachytherapy can be produced from several radionuclides in different formats. In order to reduce the price for certain types of cancer treatments with brachytherapy and allow this treatment to reach more patients, IPEN/CNEN is developing a new Iodine-125 seed. The objective of this work is to carry out part of the dosimetric characterization of this Iodine-125 seed relying on Monte Carlo simulations. [2]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call